Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Obstetrics and Gynecology|March 15, 2019
Influence of Genetic Variants on Steady-State Etonogestrel Concentrations Among Contraceptive Implant UsersAaron Lazorwitz, Christina L Aquilante, Kris Oreschak, et al.
Obstetrics and Gynecology|October 11, 2018
Nitrous Oxide Compared With Intravenous Sedation for Second-Trimester Abortion: A Randomized Controlled TrialLauren Thaxton, Jennifer Pitotti, Eve Espey, et al.
Clinical and Translational Science|March 2, 2021
Applicability of ancestral genotyping in pharmacogenomic research with hormonal contraceptionAaron Lazorwitz, Christina L Aquilante, Jonathan A Shortt, et al.
O&G Open|September 26, 2025
Pharmacogenomics of the Etonogestrel Contraceptive Implant: A Genome-Wide Association Study of Steady-State Etonogestrel ConcentrationsAaron Lazorwitz, Christina L Aquilante, Jonathan A Shortt, et al.
Obstetrics and Gynecology|May 4, 2004
A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortionMitchell D Creinin, Michelle C Fox, Stephanie Teal, et al.
Contraception|April 22, 2018
Phase I/II pharmacokinetic and pharmacodynamic evaluation of two levonorgestrel-only contraceptive patches in a multicenter randomized trialCarolyn L Westhoff, Beatrice A Chen, Jeffrey T Jensen, et al.
American Journal of Obstetrics and Gynecology|March 15, 2021
Intrauterine device use, sexually transmitted infections, and fertility: a prospective cohort studyJeffrey F Peipert, Qiuhong Zhao, Courtney A Schreiber, et al.
Obstetrics and Gynecology|March 10, 2022
Association of Obesity With Longer Time to PregnancyTaylor Burger, Joanna Li, Qiuhong Zhao, et al.
Contraception|April 26, 2024
Use of serum evaluation of contraceptive and ovarian hormones to assess reduced risk of pregnancy among women presenting for emergency contraception in a multicenter clinical trialJeffrey T Jensen, Alison Edelman, Carolyn L Westhoff, et al.
Contraception|April 25, 2024
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrelAlison Edelman, Jeffrey T Jensen, Jill Brown, et al.
Pageof 5